Owen Wallace, Ph.D.

Owen Wallace, Ph.D.

Chief Scientific OfficeratMonte Rosa Therapeutics· In proxies 2022–2023

Pay in FY2023-17% from the year before · Monte Rosa Therapeutics stock -25.8% the same year

Owen Wallace, Ph.D. was paid $1.4M in FY2023 (Dec), down 17%. Monte Rosa Therapeutics stock fell 25.8% that year.

Pay$100 in the stock at the end of FY21 → $28
Pay is from the Summary Compensation Table of each Monte Rosa Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Monte Rosa TherapeuticsPublic company · 4 yr
    • Chief Scientific Officer2022 – Present · 4 yrStock in role -46%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?